CPT 2016 Code Changes Code Changes - Medicine New CPT 2016 New Codes Code Description 69209 Removal impacted cerumen using irrigation/lavage, unilateral 90620 Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB), 2 dose schedule, for 90621 Meningococcal recombinant lipoprotein vaccine, serogroup B (MenB), 3 dose schedule, for 90625 Cholera vaccine, live, adult dosage, 1 dose schedule, for oral use Advice CPT 2016 adds 69209 to report when a r washes out (irrigates/lavages) entrapped wax (cerumen) from a patient s external ear canal. A already existed for cerumen removal using an instrument, but no existed for lavage. CPT released 90620 and 90621, two new formulations of recombinant meningococcal vaccines, on Nov. 1, 2014, for implementation Feb. 1, 2015; however, the s won't appear in the CPT manual until 2016. Code 90620 is an intramuscular, two-dose schedule, serogroup B Meningococcal recombinant protein and outer membrane vesicle vaccine and 90621 is an intramuscular, three-dose Meningococcal recombinant lipoprotein vaccine, serogroup B (MenB). These vaccines were approved by the FDA in early 2015. CPT released 90620 and 90621, two new formulations of recombinant meningococcal vaccines, on Nov. 1, 2014, for implementation Feb. 1, 2015; however, the s won't appear in the CPT until 2016. Code 90620 is an intramuscular, two-dose schedule, serogroup B Meningococcal recombinant protein and outer membrane vesicle vaccine and 90621 is an intramuscular, three-dose Meningococcal recombinant lipoprotein vaccine, serogroup B (MenB). These vaccines were approved by the FDA in early 2015. CPT 2016 adds a single dose, oral cholera vaccine for adults with 90625, Cholera vaccine, live, adult dosage, 1 dose schedule, for oral use. Until now, the set included a only for an injectable form of cholera vaccine.
90697 Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hb-HepB), for Revised CPT released 90697, Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenza type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IP- -Hib-HepB), for intramuscular, use in mid-2014, but it wasn't FDA-approved and didn't appear in the 2015 manual. It will appear in the 2016 manual. Code 90697 is a new formulation and joins a large group of other diphtheria/tetanus toxoid combination vaccines (90476-90749). CPT 2016 Revised Codes Code Description 90632 Hepatitis A vaccine (HepA), adult dosage, for 90633 Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for 90634 Hepatitis A vaccine (HepA), pediatric/adolescent dosage-3 dose schedule, for 90644 Meningococcal conjugate vaccine, serogroups C & Y and Hemophilus influenza BHaemophilus influenzae type b vaccine (Hib-MenCY), 4 dose schedule, when administered to children 2-1518 months of age, for 90647 Hemophilus influenzahaemophilus influenzae type b vaccine (Hib), PRP-OMP conjugate (, 3 dose schedule), for Advice CPT 2016 changes the wording of the official descriptor for 90632 to include the abbreviation "(HepA)" after the name of the vaccine. CPT 2016 changes the wording of the official descriptor for 90633 to include the abbreviation "(HepA)" after the name of the vaccine. CPT 2016 changes the wording of the official descriptor for 90634 to include the abbreviation "(HepA)" after the name of the vaccine. CPT 2016 changes the wording of the official descriptor for 90644 from "2-15 months of age" to "2-18 months of age." CPT 2016 removes the parentheses from "3-dose schedule" in the official descriptor for 90647 and changes the vaccine to "Haemophilus influenzae type" b. 90648 Hemophilus influenzahaemophilus influenzae type b vaccine (Hib), PRP-T conjugate (, 4 dose schedule), for CPT 2016 removes the parentheses from "4-dose schedule" in the official descriptor for 90648 and changes the vaccine to "Haemophilus influenzae type" b.
90649 Human Papilloma virus (HPV)Papillomavirus vaccine, types 6, 11, 16, 18 (quadrivalent), quadrivalent (4vHPV), 3 dose schedule, for CPT 2016 removes the abbreviation "(HPV)" and the parentheses from "quadrivalent," changes the description to "Papillomavirus" and adds "(4vHPV)" after the word quadrivalent in the official descriptor for 90649. 90650 Human Papilloma virus (HPV)Papillomavirus vaccine, types 16, 18, bivalent (2vHPV), 3 dose schedule, for 90651 Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (HPV)(9vHPV), 3 dose schedule, for 90653 Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for 90655 Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, when administered to children 6-35 months of age, for intramuscular use 90656 Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, when administered to individuals 3 years and older, for intramuscular use 90657 Influenza virus vaccine, trivalent (IIV3), split virus, when administered to children 6-35 months of age, for 90658 Influenza virus vaccine, trivalent (IIV3), split virus, when administered to individuals 3 years of age and older, for 90660 Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use 90661 Influenza virus vaccine (cciiv3), derived from cell cultures, subunit, preservative and antibiotic free, for 90662 Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for CPT 2016 removes "(HPV)" following the name of the vaccine, changes the name to "Papillomavirus" and adds "(2vHPV)" after bivalent in the official descriptor for 90650. CPT 2016 replaces "(HPV)" after nonvalent with "(ovhpv)" in the official descriptor for 90651. CPT 2016 adds "(IIV)" after "Influenza vaccine, inactivated" in the official descriptor for 90653. CPT 2016 adds "(IIV3)" after "Influenza virus vaccine, trivalent" in the official descriptor for 90655. CPT 2016 adds "(IIV3)" after "Influenza virus vaccine, trivalent" in the official descriptor for 90656. CPT 2016 adds "(IIV3)" after "Influenza virus vaccine, trivalent" in the official descriptor for 90657. CPT 2016 adds "(IIV3)" after "Influenza virus vaccine, trivalent" in the official descriptor for 90658. CPT 2016 adds "(LAIV3)" after "Influenza virus vaccine, trivalent, live" in the official descriptor for 90660. CPT 2016 adds "(cciiv3)" after "Influenza 90661. CPT 2016 adds "(IIV)" after "Influenza 90662.
90664 Influenza virus vaccine, live (LAIV), pandemic formulation, live, for intranasal use 90666 Influenza virus vaccine (IIV), pandemic formulation, split virus, preservative free, for 90667 Influenza virus vaccine (IIV), pandemic formulation, split virus, adjuvanted, for 90668 Influenza virus vaccine (IIV), pandemic formulation, split virus, for 90670 Pneumococcal conjugate vaccine, 13 valent (PCV13), for 90672 Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use 90673 Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA (RIV3), hemagglutinin (HA) protein only, preservative and antibiotic free, for 90680 Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use 90681 Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use 90685 Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, when administered to children 6-35 months of age, for 90686 Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, when administered to individuals 3 years of age and older, for 90687 Influenza virus vaccine, quadrivalent (IIV4), split virus, when administered to children 6-35 months of age, for 90688 Influenza virus vaccine, quadrivalent (IIV4), split virus, when administered to individuals 3 years of age and older, for CPT 2016 adds " live (LAIV)" after "Influenza virus vaccine" in the official descriptor for 90664 and removes "live" that follows "forumulation" in the 2015 descriptor. CPT 2016 adds "(IIV)" after "Influenza 90666. CPT 2016 adds "(IIV)" after "Influenza 90667. CPT 2016 adds "(IIV)" after "Influenza 90668. CPT 2016 adds "(PCV13)" after "Pneumococcal conjugate vaccine, 13 valent" in the official descriptor for 90670. CPT 2016 adds "(LAIV4)" after "Influenza virus vaccine, quadrivalent, live" in the official descriptor for 90672. CPT 2016 moves (RIV3) to follow Influenza virus vaccine, trivalent in the official descriptor for 90673. CPT 2016 adds "(RV5)" after "Rotavirus vaccine, pentavalent" in the official descriptor for 90680. CPT 2016 adds "(RV1)" after "Rotavirus vaccine, human, attenuated" in the official descriptor for 90681. CPT 2016 adds "(IIV4)" after "Influenza virus vaccine, quadrivalent" in the official descriptor for 90685. CPT 2016 adds "(IIV4)" after "Influenza virus vaccine, quadrivalent" in the official descriptor for 90686. CPT 2016 adds "(IIV4)" after "Influenza virus vaccine, quadrivalent" in the official descriptor for 90687. CPT 2016 adds "(IIV4)" after "Influenza virus vaccine, quadrivalent" in the official descriptor for 90688.
90696 Diphtheria, tetanus toxoids, acellular pertussis vaccine and inactivated poliovirus vaccine, inactivated (DTaP-IPV), when administered to children 4 through 6 years of age, for 90698 Diphtheria, tetanus toxoids, acellular pertussis vaccine, hhaemophilus influenza Type Binfluenzae type b, and inactivated poliovirus vaccine (DTap-IPV/Hib), for 90702 Diphtheria and tetanus toxoids adsorbed (DT) adsorbed when administered to individuals younger than 7 years, for 90714 Tetanus and diphtheria toxoids adsorbed (Td) adsorbed, preservative free, when administered to individuals 7 years or older, for 90716 Varicella virus vaccine (VAR), live, for subcutaneous use 90732 Pneumococcal polysaccharide vaccine, 23- valent (PPSV23), adult or immunosuppressed patient dosage, when administered to individuals 2 years or older, for subcutaneous or 90733 Meningococcal polysaccharide vaccine (any group(s)), serogroups A, C, Y, W-135, quadrivalent (MPSV4), for subcutaneous use 90734 Meningococcal conjugate vaccine, serogroups A, C, Y and W-135, quadrivalent (MenACWY), for 90736 Zoster (shingles) vaccine (HZV), live, for subcutaneous injection 90739 Hepatitis B vaccine (HepB), adult dosage (, 2 dose schedule), for 90740 Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage (, 3 dose schedule), for CPT 2016 changes poliovirus vaccine, inactivated (DTaP-IPV) to inactivated poliovirus vaccine (DTaP-IPV) in the official descriptor for 90696. CPT 2016 changes influenza Type B, and poliovirus vaccine to influenza tupe b, and inactived poliovirus vaccine (DTap-IPV/Hib) in the official descriptor for 90698. CPT 2016 moves "absorbed" from after (DT) to before (DT) in the official descriptor for 90702. CPT 2016 moves "absorbed" from after (Td) to after (Td) in the official descriptor for 90714. CPT 2016 adds "(VAR)" after "Varicella 90716. CPT 2016 adds "(PPSV23)" after "Pneumococcal polysaccharide vaccine, 23- valent" in the official descriptor for 90732. CPT 2016 changes the words "(any group(s))" in the official descriptor to "serogroups A, C, Y, W-135, quadrivalent (MPSV4)" for 90733. CPT 2016 adds "(MenACWY)" after the word "quadrivalent" in the official descriptor for 90734. CPT 2016 adds "(HZV)" after the word "vaccine" in the official descripto for 90736. from 2 dose schedule in the official descriptor for 90739. from 3 dose schedule in the official descriptor for 90740.
90743 Hepatitis B vaccine (HepB), adolescent (, 2 dose schedule), for 90744 Hepatitis B vaccine (HepB), pediatric/adolescent dosage (, 3 dose schedule), for 90746 Hepatitis B vaccine (HepB), adult dosage (, 3 dose schedule), for 90747 Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage (, 4 dose schedule), for 90748 Hepatitis B and Hemophilus influenzahaemophilus influenzae type b vaccine (HepB-Hib)(Hib-HepB), for Deleted from 2 dose schedule in the official descriptor for 90743. from 3 dose schedule in the official descripto for 90744. from 3 dose schedule in the official descriptor for 90746. from 4 dose schedule in the official descriptor for 90747. CPT 2016 changes Hemophilus influenza to "Haemophilus influenzae type" and changes (HepB-Hib) to "(Hib-HepB) in the official descriptor for 90748. CPT 2016 Deleted Codes Code Description 90645 Hemophilus influenza b vaccine (Hib), HbOC conjugate (4 dose schedule), for 90646 Hemophilus influenza b vaccine (Hib), PRP-D conjugate, for booster use only, Crosswalk Code s for s for Advice The 2016 set 90645 as an obsolete vaccine. The 2016 set 90645 as an obsolete vaccine.
90669 Pneumococcal conjugate vaccine, 7 valent, for 90692 Typhoid vaccine, heat- and phenolinactivated (H-P), for subcutaneous or intradermal use 90693 Typhoid vaccine, acetone-killed, dried (AKD), for subcutaneous use (U.S. military) 90703 Tetanus toxoid adsorbed, for s for s for s for s for The 2016 set 90669. At time, CPT an indication as to the reason for deletion of. CPT also a for but check with the individual payers for their policies on s to report for service. Refer to the CPT manual also for further direction as you may be able to report service or procedure using an unlisted. Remember to send supporting documentation to payers with any claim containing an unlisted. Keep in mind that CPT recommend the use of unlisted procedures on a regular basis. The 2016 set 90692 as an obsolete vaccine. The 2016 set 90693 as an obsolete vaccine. The 2016 set 90703 as an obsolete vaccine.
90704 Mumps virus vaccine, live, for subcutaneous use 90705 Measles virus vaccine, live, for subcutaneous use 90706 Rubella virus vaccine, live, for subcutaneous use 90708 Measles and rubella virus vaccine, live, for subcutaneous use 90712 Poliovirus vaccine, (any type[s]) (OPV), live, for oral use s for s for s for s for s for The 2016 set 90704 as an obsolete vaccine. The 2016 set 90705 as an obsolete vaccine. The 2016 set 90706 as an obsolete vaccine. The 2016 set 90708 as an obsolete vaccine. The 2016 set 90712 as an obsolete vaccine.
90719 Diphtheria toxoid, for intramuscular use 90720 Diphtheria, tetanus toxoids, and whole cell pertussis vaccine and Hemophilus influenza B vaccine (DTP-Hib), for 90721 Diphtheria, tetanus toxoids, and acellular pertussis vaccine and Hemophilus influenza B vaccine (DTaP/Hib), for s for s for s for 90725 Cholera vaccine for injectable use s for 90727 Plague vaccine, for s for The 2016 set 90719 as an obsolete vaccine. The 2016 set 90720 as an obsolete vaccine. The 2016 set 90721 as an obsolete vaccine. The 2016 set 90725 as an obsolete vaccine. The 2016 set 90727 as an obsolete vaccine.
90735 Japanese encephalitis virus vaccine, for subcutaneous use s for The 2016 set 90735 as an obsolete vaccine.